---
figid: PMC5642500__oncotarget-08-69559-g007
figtitle: HCaRG/COMMD5 inhibits ErbB receptor-driven renal cell carcinoma
organisms:
- NA
pmcid: PMC5642500
filename: oncotarget-08-69559-g007.jpg
figlink: /pmc/articles/PMC5642500/figure/F7/
number: F7
caption: Cancer cells overexpressing HCaRG show a more differentiated phenotype with
  lower cell proliferation than Neo-controls. HCaRG inhibits the phosphorylation of
  the proto-oncogene ErbB2 and inactivates subsequent MAPK and PI3K/AKT pathways by
  inducing the epigenetic gene silencing of EGFR and ErbB3 genes through their promoter
  methylation (Me). In addition, HCaRG facilitates programmed cell death by inducing
  autophagy via inactivation of AKT/mTOR pathway. As a result, tumor growth and angiogenesis
  of RCC are inhibited by HCaRG. The blue color indicates down-regulation or de-phosphorylation.
  The red color indicates up-regulation or activation.
papertitle: HCaRG/COMMD5 inhibits ErbB receptor-driven renal cell carcinoma.
reftext: Hiroyuki Matsuda, et al. Oncotarget. 2017 Sep 19;8(41):69559-69576.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.965816
figid_alias: PMC5642500__F7
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC5642500__F7
ndex: 52c9139a-dece-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5642500__oncotarget-08-69559-g007.html
  '@type': Dataset
  description: Cancer cells overexpressing HCaRG show a more differentiated phenotype
    with lower cell proliferation than Neo-controls. HCaRG inhibits the phosphorylation
    of the proto-oncogene ErbB2 and inactivates subsequent MAPK and PI3K/AKT pathways
    by inducing the epigenetic gene silencing of EGFR and ErbB3 genes through their
    promoter methylation (Me). In addition, HCaRG facilitates programmed cell death
    by inducing autophagy via inactivation of AKT/mTOR pathway. As a result, tumor
    growth and angiogenesis of RCC are inhibited by HCaRG. The blue color indicates
    down-regulation or de-phosphorylation. The red color indicates up-regulation or
    activation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Shc
  - Pdk1
  - drk
  - Myb
  - Pi3K21B
  - Taf5
  - Rpn5
  - Caf1-55
  - cav
  - MKP-4
  - p38b
  - rl
  - ras
  - Ras64B
  - Ras85D
  - Akt
  - pk
  - Raf
  - Mtor
  - Tor
  - IKKepsilon
  - key
  - IKKbeta
  - Dsor1
  - Vhl
  - foxo
  - sima
  - Dif
  - dl
  - Rel
  - dap
  - Egfr
  - CycE
  - cyc
  - SHC1
  - SHC2
  - SHC3
  - SHC4
  - PIK3CA
  - PDK1
  - PDPK1
  - GRB2
  - PIK3R1
  - PIK3R2
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - ERG
  - FOS
  - IL2RA
  - PSMD12
  - FSCN1
  - TNFRSF1A
  - PIK3R3
  - PMPCA
  - H3P44
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - KRAS
  - HRAS
  - NRAS
  - AKT1
  - AKT2
  - AKT3
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MTOR
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - MAP2K1
  - MAP2K2
  - VHL
  - COMMD5
  - MAP1LC3B
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - HIF1A
  - NFKB1
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - ERBB3
  - EGFR
  - XRCC1
  - PBRM1
  - ERBB2
  - ERBB4
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
